img

Global Plasmid DNA CDMO Market Segment Research Report 2024

Published on: 2024-01-04 | No of Pages : 420 | Industry : Pharma & Healthcare Research Center

Publisher : MRX | Format : PDF

Global Plasmid DNA CDMO Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Plasmid DNA CDMO Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Plasmid DNA CDMO industry at home and abroad, estimate the overall market scale of the Plasmid DNA CDMO industry and the market share of major countries, Plasmid DNA CDMO industry, and study and judge the downstream market demand of Plasmid DNA CDMO through systematic research, Analyze the competition pattern of Plasmid DNA CDMO, so as to help solve the pain points of various stakeholders in Plasmid DNA CDMO industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Plasmid DNA CDMO Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Plasmid DNA CDMO Market?
GenScript ProBio
Biovian
Biomay
VGXI
Esco Aster
Delphi Genetics
Richter-Helm BioLogics
Cytovance Biologics
Cobra Biologics
Obiosh
Thermo Fisher
Aldevron(Danaher)
Cognate BioServices (Charles River Laboratories)
Pharmaron Inc.
Porton
WuXi AppTec
AGC Biologics
Major Type of Plasmid DNA CDMO Covered in XYZResearch report
GMP Grade Plasmid DNA
Non-GMP Grade Plasmid DNA
Application Segments Covered in XYZResearch Market
DNA Vaccines
Gene Therapy
Immunotherapy
Others

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Plasmid DNA CDMO Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Plasmid DNA CDMO Market by Value
2.2.1 Global Plasmid DNA CDMO Revenue by Type
2.2.2 Global Plasmid DNA CDMO Market by Value (%)
2.3 Global Plasmid DNA CDMO Market by Production
2.3.1 Global Plasmid DNA CDMO Production by Type
2.3.2 Global Plasmid DNA CDMO Market by Production (%)

3. The Major Driver of Plasmid DNA CDMO Industry
3.1 Historical & Forecast Global Plasmid DNA CDMO Demand
3.2 Largest Application for Plasmid DNA CDMO (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Plasmid DNA CDMO Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Plasmid DNA CDMO Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Plasmid DNA CDMO Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Plasmid DNA CDMO Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Plasmid DNA CDMO Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Plasmid DNA CDMO Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Plasmid DNA CDMO Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Plasmid DNA CDMO Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Plasmid DNA CDMO Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Plasmid DNA CDMO Average Price Trend
12.1 Market Price for Each Type of Plasmid DNA CDMO in US (2018-2022)
12.2 Market Price for Each Type of Plasmid DNA CDMO in Europe (2018-2022)
12.3 Market Price for Each Type of Plasmid DNA CDMO in China (2018-2022)
12.4 Market Price for Each Type of Plasmid DNA CDMO in Japan (2018-2022)
12.5 Market Price for Each Type of Plasmid DNA CDMO in India (2018-2022)
12.6 Market Price for Each Type of Plasmid DNA CDMO in Korea (2018-2022)
12.7 Market Price for Each Type of Plasmid DNA CDMO in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Plasmid DNA CDMO Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Plasmid DNA CDMO

14. Plasmid DNA CDMO Competitive Landscape
14.1 GenScript ProBio
14.1.1 GenScript ProBio Company Profiles
14.1.2 GenScript ProBio Product Introduction
14.1.3 GenScript ProBio Plasmid DNA CDMO Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Biovian
14.2.1 Biovian Company Profiles
14.2.2 Biovian Product Introduction
14.2.3 Biovian Plasmid DNA CDMO Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Biomay
14.3.1 Biomay Company Profiles
14.3.2 Biomay Product Introduction
14.3.3 Biomay Plasmid DNA CDMO Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 VGXI
14.4.1 VGXI Company Profiles
14.4.2 VGXI Product Introduction
14.4.3 VGXI Plasmid DNA CDMO Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Esco Aster
14.5.1 Esco Aster Company Profiles
14.5.2 Esco Aster Product Introduction
14.5.3 Esco Aster Plasmid DNA CDMO Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Delphi Genetics
14.6.1 Delphi Genetics Company Profiles
14.6.2 Delphi Genetics Product Introduction
14.6.3 Delphi Genetics Plasmid DNA CDMO Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Richter-Helm BioLogics
14.7.1 Richter-Helm BioLogics Company Profiles
14.7.2 Richter-Helm BioLogics Product Introduction
14.7.3 Richter-Helm BioLogics Plasmid DNA CDMO Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Cytovance Biologics
14.8.1 Cytovance Biologics Company Profiles
14.8.2 Cytovance Biologics Product Introduction
14.8.3 Cytovance Biologics Plasmid DNA CDMO Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Cobra Biologics
14.9.1 Cobra Biologics Company Profiles
14.9.2 Cobra Biologics Product Introduction
14.9.3 Cobra Biologics Plasmid DNA CDMO Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Obiosh
14.10.1 Obiosh Company Profiles
14.10.2 Obiosh Product Introduction
14.10.3 Obiosh Plasmid DNA CDMO Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Thermo Fisher
14.12 Aldevron(Danaher)
14.13 Cognate BioServices (Charles River Laboratories)
14.14 Pharmaron Inc.
14.15 Porton
14.16 WuXi AppTec
14.17 AGC Biologics
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Plasmid DNA CDMO Industry (Volume)
Figure 2. Plasmid DNA CDMO Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Plasmid DNA CDMO Revenue in 2022
Figure 5. US Plasmid DNA CDMO Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Plasmid DNA CDMO Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Plasmid DNA CDMO Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Plasmid DNA CDMO Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Plasmid DNA CDMO Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Plasmid DNA CDMO Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Plasmid DNA CDMO Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Plasmid DNA CDMO Revenue, by Type (Million USD) (2018-2028)
Table 4. Plasmid DNA CDMO Production, by Type (K Unit) (2018-2028)
Table 5. Plasmid DNA CDMO Demand (K Unit) by Application (2018-2028)
Table 6. Plasmid DNA CDMO Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Plasmid DNA CDMO Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Plasmid DNA CDMO Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Plasmid DNA CDMO Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Plasmid DNA CDMO Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Plasmid DNA CDMO Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Plasmid DNA CDMO Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Plasmid DNA CDMO Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Plasmid DNA CDMO Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Plasmid DNA CDMO in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Plasmid DNA CDMO in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Plasmid DNA CDMO in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Plasmid DNA CDMO in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Plasmid DNA CDMO in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Plasmid DNA CDMO in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Plasmid DNA CDMO in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. GenScript ProBio Profiles
Table 61. GenScript ProBio Plasmid DNA CDMO Product Introduction
Table 62. GenScript ProBio Plasmid DNA CDMO Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. GenScript ProBio Strategic initiatives
Table 64. Biovian Profiles
Table 65. Biovian Plasmid DNA CDMO Product Introduction
Table 66. Biovian Plasmid DNA CDMO Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Biovian Strategic initiatives
Table 68. Biomay Profiles
Table 69. Biomay Plasmid DNA CDMO Product Introduction
Table 70. Biomay Plasmid DNA CDMO Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Biomay Strategic initiatives
Table 72. VGXI Profiles
Table 73. VGXI Plasmid DNA CDMO Product Introduction
Table 74. VGXI Plasmid DNA CDMO Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. VGXI Strategic initiatives
Table 76. Esco Aster Profiles
Table 77. Esco Aster Plasmid DNA CDMO Product Introduction
Table 78. Esco Aster Plasmid DNA CDMO Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Esco Aster Strategic initiatives
Table 80. Delphi Genetics Profiles
Table 81. Delphi Genetics Plasmid DNA CDMO Product Introduction
Table 82. Delphi Genetics Plasmid DNA CDMO Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Delphi Genetics Strategic initiatives
Table 84. Richter-Helm BioLogics Profiles
Table 85. Richter-Helm BioLogics Plasmid DNA CDMO Product Introduction
Table 86. Richter-Helm BioLogics Plasmid DNA CDMO Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Richter-Helm BioLogics Strategic initiatives
Table 88. Cytovance Biologics Profiles
Table 89. Cytovance Biologics Plasmid DNA CDMO Product Introduction
Table 90. Cytovance Biologics Plasmid DNA CDMO Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Cytovance Biologics Strategic initiatives
Table 92. Cobra Biologics Profiles
Table 93. Cobra Biologics Plasmid DNA CDMO Product Introduction
Table 94. Cobra Biologics Plasmid DNA CDMO Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Cobra Biologics Strategic initiatives
Table 97. Obiosh Profiles
Table 98. Obiosh Plasmid DNA CDMO Product Introduction
Table 99. Obiosh Plasmid DNA CDMO Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Obiosh Strategic initiatives
Table 101. Thermo Fisher Profiles
Table 102. Thermo Fisher Plasmid DNA CDMO Product Introduction
Table 103. Thermo Fisher Plasmid DNA CDMO Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Thermo Fisher Strategic initiatives
Table 105. Aldevron(Danaher) Profiles
Table 106. Aldevron(Danaher) Plasmid DNA CDMO Product Introduction
Table 107. Aldevron(Danaher) Plasmid DNA CDMO Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. Aldevron(Danaher) Strategic initiatives
Table 109. Cognate BioServices (Charles River Laboratories) Profiles
Table 110. Cognate BioServices (Charles River Laboratories) Plasmid DNA CDMO Product Introduction
Table 111. Cognate BioServices (Charles River Laboratories) Plasmid DNA CDMO Production (Unit), Revenue (Million USD) (2018-2022)
Table 112. Cognate BioServices (Charles River Laboratories) Strategic initiatives
Table 113. Pharmaron Inc. Profiles
Table 114. Pharmaron Inc. Plasmid DNA CDMO Product Introduction
Table 115. Pharmaron Inc. Plasmid DNA CDMO Production (Unit), Revenue (Million USD) (2018-2022)
Table 116. Pharmaron Inc. Strategic initiatives
Table 117. Porton Profiles
Table 118. Porton Plasmid DNA CDMO Product Introduction
Table 119. Porton Plasmid DNA CDMO Production (Unit), Revenue (Million USD) (2018-2022)
Table 120. Porton Strategic initiatives
Table 121. WuXi AppTec Profiles
Table 122. WuXi AppTec Plasmid DNA CDMO Product Introduction
Table 123. WuXi AppTec Plasmid DNA CDMO Production (Unit), Revenue (Million USD) (2018-2022)
Table 124. WuXi AppTec Strategic initiatives
Table 125. AGC Biologics Profiles
Table 126. AGC Biologics Plasmid DNA CDMO Product Introduction
Table 127. AGC Biologics Plasmid DNA CDMO Production (Unit), Revenue (Million USD) (2018-2022)
Table 128. AGC Biologics Strategic initiatives

Select User License

$4850 Single Licence
$5850 Enterprise Licence
$6850 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries